Compare Tesla, Inc. (TSLA) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tesla, Inc. vs UnitedHealth Group Inc — how do they compare? Tesla, Inc. trades at $379.25 (market cap $1.39T), while UnitedHealth Group Inc trades at $436.58 (market cap $382.83B). The key difference: Tesla, Inc. is far larger — about 3.6× UnitedHealth Group Inc's market cap, and UnitedHealth Group Inc pays a 2.2% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| TSLA | UNH | |
|---|---|---|
Market Cap | $1.39T | $382.83B |
Sector | Consumer Cyclical | Health |
52-Week High | $489.88 | $431.68 |
52-Week Low | $302.63 | $237.77 |
Enterprise Value | $1.36T | $429.52B |
Dividend Yield | — | 2.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tesla trades at $378.99, down 0.49% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows elevated valuation ratios (P/E 339.06, P/S 13.34) despite recent earnings beats in Q4 2025 and Q1 2026. Revenue declined to $94.83B in 2025, with net income margin compressing to 3.95%. Positive developments include regulatory approval for driver-assistance software in Europe and a potential cheaper EV model, though delivery misses and competitive pressures weigh on sentiment.
Tesla's outlook balances innovation in autonomy and energy against slowing auto growth and high valuations. The consensus price target of $409.26 suggests modest upside, but risks include execution on robotaxis, margin pressure, and macroeconomic headwinds. Institutional ownership shifts and mixed analyst ratings (38% Buy, 43% Hold) reflect cautious optimism, with the stock's trajectory hinging on AI and energy segments offsetting EV deceleration.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
